also an important factor affecting the absolute velocity. The CBF does not remain constant during the first 3 weeks after SAH, depending on several reasons in addition to arterial spasm. 45 Two indices have been proposed to incorporate CBF variations in the evaluation of cerebral vasospasm. Lindegaard et al., 40 who evaluated the ICA and the MCA as two different levels along one line of flow in an end artery, suggested that by calculating the ratio between the velocity in the MCA and the ipsilateral ICA the influence of flow variations could be corrected. Jakobsen et al. 29 described the ratio between TCD velocities and CBF, which was measured with the 133 Xe inhalation technique. In their study the index remained remarkably stable, even in patients with wide dayto-day variations in the MCA velocities or in CBF.
Although a considerable amount of literature has been devoted to analyzing the correlation between TCD velocities and vasospasm, 2, 9, 12, 18, 21, 39, 40, 55, 65 only one study has focused on defining the sensitivity, specificity, and predictive values of specific ranges of TCD velocities and Lindegaard ratio for the detection of cerebral vasospasm. 64 This study showed that only very low or very high TCD velocities reliably predicted the presence of clinically significant angiographic vasospasm in the MCA. In addition, the authors could not show improvement of the predictive values of TCD monitoring when Lindegaard ratios were considered. The Jakobsen spasm index was not evaluated.
The purpose of our study was to use a statistical approach to analyze clinical aspects that have been recognized as risk factors for the development of cerebral vasospasm and to create a combined index (which we call the VPI), adding to the TCD velocities the significant factors that could improve our current accuracy in the diagnosis of cerebral vasospasm after SAH.
Clinical Material and Methods

Patient Population
Seven hundred ninety-five consecutive patients with aneurysmal SAH demonstrated on CT scans and with angiographic confirmation of one or more intracranial aneurysms underwent TCD studies between April 1998 and January 2000 at the University of California Los Angeles Center for Health Sciences. The retrospective review of charts and angiographic studies was performed in accordance with our institutional review board regulations under an approved protocol (UCLA IRB# G04-02-070-01). Angiography was performed within 24 hours of the TCD examination in 154 patients, and in 75, 133 Xe CBF studies were obtained the same day. Seven cases were excluded because measurements of the MCA velocities were not obtained due to a limited sonographic window. This final group of 68 patients constitutes the population of our study.
Demographic Data
There were 41 women (60.3%) and 27 men (39.7%). Their age range was 35 to 84 years, with a mean age of 58.0 Ϯ 13.2 years. Figure 1 shows the distribution of patients in whom TCD, CBF, and angiography studies were performed within 24 hours according to the parameter "days after SAH."
Clinical Features
Clinical characteristics that were collected included age, sex, Hunt and Hess grade, 26 Fisher grade, 16 days after SAH, day of treatment, type of treatment (coil embolization, surgical clip placement, or conservative treatment), smoking history, hypertension history, and other antecedents (drug abuse, previous SAH, cancer, and so on). All patients in whom aneurysmal SAH is diagnosed are treated in our institution with nimodipine (Bayer Group) from admission to Day 15 post-SAH, and with volume expansion as needed.
The diagnosis of clinical vasospasm was made as an exclusion diagnosis, based on the onset of global or focal neurological deterioration not explained by other causes such as hydrocephalus, hemorrhage, surgical complications, metabolic abnormalities, or infection, according to the notes of the neurointensive care team. No retrospective diagnosis of clinical vasospasm was performed. The day of the initial SAH was defined as Day 0. The TCD, CBF, and angiography studies were performed between Days 1 and 17.
Transcranial Doppler Evaluation
The TCD studies are performed in our institution as soon as the diagnosis of SAH is established. Therefore, in some cases the data are obtained before the clinical high-risk period of vasospasm begins, and these are used as the baseline to be compared with further TCD examinations.
All TCD measurements were obtained using a standard TCD machine (Neuroguard Cerebrovascular Diagnostic System, Nicolet Biomedical, Inc.) with a 2-MHz, pulsed, range-gated transducer. The mean CBF velocities were obtained using the technique described in prior publications. 2 The Lindegaard ratio was calculated bilaterally as the ratio of the MCA velocity to the ipsilateral extracranial ICA velocity, in accordance with the original description of the ratio. 38 
Cerebral Blood Flow Evaluation
The CBF studies were performed at the bedside by using a standard CBF portable unit (Cerebrograph Cortexplorer 10, Ceretronix) with the 133 Xe clearance technique. 53 
Angiographic Evaluation
Digital subtraction angiography was performed at patient presentation to confirm the presence of intracranial aneurysms and when there was clinical or TCD-based suspicion of vasospasm. Therefore, the patients in our study include individuals with a low risk of vasospasm who underwent TCD as a baseline study and angiography for diagnostic confirmation or treatment planning, and patients within the high-risk period of vasospasm with clinical or TCD-supported suspicion of cerebral vasospasm.
Angiograms were performed by members of the interventional neuroradiology team at our institution. Anteroposterior and lateral views of the ICA injections were selected. All the images were digitalized using a standard scanner machine. Identification labels were erased, and identification numbers were assigned. Digital pictures were saved as high-resolution (500-1000 ppi) grayscale images in a TIFF format. One neuroradiologist who was blinded to the TCD, CBF, and clinical information measured the arterial calibers by using the NIH Image program (developed at the US National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-image/). Corrections for magnification were made using the diameter of the ICA in the extradural portion as the reference. Corrections were performed according to sex by using the measurement technique described by Gabrielsen and Greitz 17 and previously applied in similar studies. 15, 38, 47, 49 On the digital images, the supraclinoid ICA (5 mm below the bifurcation or at its narrowest point), segment M 1 of the MCA (5 mm after the bifurcation or at its narrowest point), and the M 2 segment (5 mm after the vertical turn at the sylvian fissure) were measured. Each arterial site was measured three times at three different time points, and the results were averaged. A reliability test-retest was performed on 40 images, and the Pearson correlation coefficients for the original and repeated measures were calculated. Angiographic vasospasm was diagnosed when a reduction of 25% or more of the normal diameter was demonstrated in the measurements of any arterial segment. 38, 40, 51 
Statistical Analysis
Analysis was performed using SAS version 8.2 statistical software (SAS Institute). Logarithmic transformations of MCA velocity, Lindegaard ratio, and spasm index (TCD velocity/hemispheric CBF) were used to reduce skewness in the distributions of these variables. Each side of the patient's brain was considered separately for the analysis, with intrapatient correlation adjusted as discussed hereafter.
Two-by-two contingency tables were constructed to calculate the sensitivity, specificity, PPV, NPV, and global accuracy of the different evaluated tests. Repeated-measures binomial logistic regression (the GENMOD procedure in the SAS program) was used to evaluate predictive models of artery-specific vasospasm. Patient-level predictors considered were age, sex, time after bleeding, timing of treatment (time before protection of the aneurysm), smoking history, hypertension history, Hunt and Hess grades, Fisher grades, and type of aneurysm treatment (coil embolization, surgical clip placement, or conservative therapy). Arteryspecific predictors considered were TCD velocities, CBF hemispheric measures, spasm index, and Lindegaard ratio. Parsimonious models were developed using best subset techniques.
The ROC curves 56, 62 were constructed to illustrate the ability of the different predictors independently and the combined multivariate model to predict angiographic and clinical vasospasm. The area below the ROC curve was calculated to obtain the global accuracy of each predictor and the combined model. Jackknifed (onefold cross-validated) classification tables were constructed to assess the sensitivity, specificity, and global accuracy of the regression models. The means are given Ϯ standard deviations. treated with coil embolization, and seven (10.3%) received both treatments. These seven include two patients in whom the surgical attempt failed and five with multiple intracranial aneurysms that were treated with surgical and interventional techniques. Four patients (5.9%) were treated conservatively. The mean day of treatment (protection of aneurysm) was 3.31 Ϯ 3.39 days after SAH (range 0-15 days). Figure 3 shows the distribution of cases according to day of treatment.
Results
The
The mean age of patients in the surgical treatment group was 54.0 Ϯ 10.4 years, whereas for patients treated with coil embolization it was 62.4 Ϯ 12.7 years (p = 0.01). The mean day of treatment in the surgical group was 2.5 Ϯ 1.7 days, compared with 5.0 Ϯ 3.4 days for patients treated with coil embolization (p = 0.03). The distribution of patients according to the Hunt and Hess grades and the type of treatment received is depicted in Fig. 4 . The distribution of patients according to the Fisher grades and the type of treatment is shown in Fig. 5 .
Clinical Vasospasm
Symptomatic vasospasm was diagnosed in 18 patients (26.5%). The mean age of patients with clinical vasospasm was 56.9 Ϯ 16.2 years, which was not significantly different from the mean age of patients without vasospasm (mean 58.4 Ϯ 12.1 years, p = 0.7). The mean MCA velocity in arteries with vasospasm was 147.9 Ϯ 57.0 cm/second, which was significantly different from the mean MCA velocity in arteries without vasospasm (mean 83.1 Ϯ 41.1 cm/second, p Ͻ 0.0001). The mean Lindegaard ratio was 5.14 Ϯ 2.48 for arteries with vasospasm, compared with 2.42 Ϯ 1.01 in patients without cerebral vasospasm (p Ͻ 0.0001). The mean spasm index for arteries with vasospasm was 5.11 Ϯ 2.11, whereas it was 2.32 Ϯ 1.05 in arteries without vasospasm (p Ͻ 0.0001). No significant differences were found for the day of treatment or the day of examination: 3.4 Ϯ 2.5 days for patients with vasospasm compared with 3.3 Ϯ 3.7 days for those without it.
The distribution of cases for patients with and without clinical vasospasm according to the Hunt and Hess and Fisher grades is shown in Table 3 . Incidence of vasospasm among smokers was slightly elevated, but not significantly. The OR for smokers to develop vasospasm was 1.7 (95% CI 0.6-5.4, p = 0.4). Hypertension had a statistically significant negative association with vasospasm incidence. The OR for hypertensive patients to develop vasospasm was 0.2 (95% CI 0.04-0.9, p = 0.04). The type of treatment (coil embolization compared with surgical clip placement) did not affect the risk of developing vasospasm.
Reliability of Angiographic Measures
A reliability test-retest was performed on 40 images, and Pearson correlation coefficients for the original and repeated angiographic measures were calculated. The mean difference found was 0.005 mm (95% CI -0.007 to 0.011 mm). The Pearson correlation coefficient for the original and repeated measurements was 0.99.
Angiographic Vasospasm
Thirty-three patients (48.5%) had angiographic evidence of vasospasm. The mean age of patients with angiographic vasospasm was 55.4 Ϯ 12.1 years, compared with 60.5 Ϯ 13.9 years for those without it (p = 0.1). The mean MCA velocity of arteries with angiographic vasospasm was 142.7 Ϯ 62.0 cm/second, which was significantly different from those without vasospasm (mean 77.5 Ϯ 32.4 cm/second, p Ͻ 0.0001). The mean Lindegaard ratio in arteries with vasospasm was 4.76 Ϯ 2.35, compared with 2.29 Ϯ 0.79 in those without cerebral vasospasm (p Ͻ 0.0001). The mean spasm index for arteries with angiographic vasospasm was 4.49 Ϯ 2.17, whereas it was 2.27 Ϯ 1.01 in arteries without vasospasm (p Ͻ 0.0001).
The distribution of cases for patients with and without angiographic vasospasm according to the Hunt and Hess and Fisher grades is shown in Table 3 . The analysis of clinical antecedents that may affect the incidence of angiographic vasospasm revealed that the OR for smokers to develop angiographic vasospasm was 2.9 (95% CI 1.0-8.8, p = 0.05). The OR of having hypertension and developing angiographic vasospasm was 0.3 (95% CI 0.1-0.9, p = 0.04). No significant differences in the presence of angiographic vasospasm were observed between patients who underwent endovascular and those who received surgical treatment.
Sensitivity, Specificity, and Predictive Values of TCD Velocities, Lindegaard Ratio, and Spasm Index for Confirmation of Clinical Vasospasm
For TCD velocities above 120 cm/second at the MCA, the sensitivity was 69.2%, specificity was 84.4%, PPV was 54.5%, NPV was 91.0%, and global accuracy was 81.1% for the confirmation of clinical vasospasm. A Lindegaard ratio higher than 3.0 had a sensitivity of 76.9%, specificity of 87.4%, PPV of 64.5%, NPV of 92.7%, and global accuracy of 85.0%, which is superior to the MCA velocities alone. A spasm index higher than 3.5 had a sensitivity of 73.1%, specificity of 84.4%, PPV of 55.9%, NPV of 92.0%, and global accuracy of 82.0% for the confirmation of clinical vasospasm.
Sensitivity, Specificity, and Predictive Values of TCD Velocities, Lindegaard Ratio, and Spasm Index for Diagnosis of Angiographic Vasospasm
For TCD velocities above 120 cm/second at the MCA, the sensitivity was 58.3%, specificity was 85.9%, PPV was 65.6%, NPV was 81.7%, and global accuracy was 77.2% for the diagnosis of angiographic vasospasm. A Lindegaard ratio higher than 3.0 had a sensitivity of 77.8%, specificity of 85.7%, PPV of 71.8%, NPV of 89.2%, and global accuracy of 83.2%. A spasm index higher than 3.5 had a sensitivity of 66.7%, specificity of 88.5%, PPV of 72.7%, NPV of 85.23%, and global accuracy of 81.6% for the diagnosis of angiographic vasospasm.
Predictors of Cerebral Vasospasm
Repeated-measures logistic regression analysis was used to examine various factors that have been linked in the literature with the development of clinical and angiographic vasospasm as follows: age, sex, Hunt and Hess grades, Fisher grade, smoking history, day of SAH, day of treatment, endovascular coil embolization, surgical clip occlusion, TCD velocities, Lindegaard ratio, and spasm index. It was found that the best multivariate model for confirmation of clinical vasospasm used the Fisher grade, Hunt and Hess grade, and spasm index; complete results are shown in Table 4 . For the diagnosis of angiographic vasospasm, the logistic regression analysis revealed that the best multivariate model contained Fisher grade, Hunt and Hess grade, and Lindegaard ratio; these results are summarized in Table 5 .
Vasospasm Probability Index: Combined Diagnosis of Vasospasm
Using the results that have been presented earlier in this article, it was possible to create a combined VPI for cerebral vasospasm. The logistic model gives the probability that the outcome (presence or absence of clinical or angiographic vasospasm) occurs as an exponential function of the independent variables. According to the logistic model, the probability of clinical vasospasm is equal to (Table 4) . Similarly, the probability of angiographic vasospasm is equal to
where k 2 is the intercept term, and e, f, g, and h are the coefficients for the predictors (Table 5 ). The ROC curves (Figs. 6 and 7) show that the VPI for the confirmation of clinical vasospasm has a global accuracy of 92.9%, with onefold cross-validated sensitivity and specificity of 85 and 84%, respectively, and these values are superior to those obtained for the variables independently. Similarly, the VPI for the diagnosis of angiographic vasospasm has a global accuracy of 89.9%, with onefold cross-validated sensitivity and specificity of 81 and 78%, respectively, which is superior to any individual variable's efficacy. As an alternative interpretation, given the predictors Fisher grade, Hunt and Hess grade, Lindegaard ratio, and spasm index, the aforementioned formulas for P(Clin Spasm) and P(AngioSpasm) can be computed. Then, arteries with P(ClinSpasm) greater than or equal to 22% are confirmed to have clinical vasospasm, and angiographic vasospasm is diagnosed in those with P(AngioSpasm) greater than or equal to 22%.
Discussion
Several studies of the efficacy of TCD in the evaluation of cerebral vasospasm have pointed out the importance of combining the plain results of the TCD velocities with additional information such as velocities in the ICA, the CBF, or clinical factors that could support the diagnosis of vasospasm. 2, 9, 12, 14, 18, 21, 39, 40, 48, 55, 65 Nevertheless, these studies have failed to show which factors significantly influence the presence of vasospasm and to develop a comprehensive approach that encompasses these factors for the clinician to consider when the evaluation of a patient at risk for vasospasm is required.
The traditional clinical approach is based on a subjective estimation of the weight of those factors, including the clinical condition of the patient, degree of SAH, time after bleeding, TCD velocities, Lindegaard ratio, spasm index, and CBF values according to the experience of the neurocritical care team. Most studies of the efficacy of TCD have focused on general correlations between TCD velocities and angiographic findings or comparisons of means. These studies present some limitations of a statistical and clinical nature. From the statistical point of view, many of these investigators have not considered the retrospective nature of their design and have applied statistical methods which, used in a proper manner, should be limited to prospective cohorts. Also, the analysis of the distribution of observations to establish their normal or skewed pattern and the nature of their relations (linear, exponential, or complex) has been generally ignored.
From the clinical point of view, the results of those studies are useful as evidence of the relationship between TCD and vasospasm and the nature of that relationship, but they do not provide practical assistance to clinicians who wish to quantify the probability of the presence or absence of vasospasm based on these techniques. The approach presented here makes use of our experience in a significant number of cases to weigh those factors that the clinician should consider, allows a consistent use of this information translated into a "probability" of having vasospasm, and emphasizes the importance of the CBF measures to interpret the TCD values.
Many of the previous studies have identified the importance of caution in the interpretation of TCD velocities alone and the crucial importance of combining that information with other factors. In a very carefully executed paper, Vora et al. 64 identified some of the same problems that we have mentioned and adopted an interesting approach to determine the predictive values and likelihood ratios of TCD velocities for diagnosis of moderate to severe angiographic vasospasm. This study showed that only very low or very high TCD velocities reliably predicted the presence of clinically significant angiographic vasospasm in the MCA. In addition, the authors could not show improvement of the predictive values of TCD monitoring when Lindegaard ratios were considered. The Jakobsen spasm index was not evaluated.
In our study we have attempted to go beyond the evaluation of the isolated TCD and to provide a method that, by using the clinical factors and diagnostic tests available, could increase the accuracy of our current approach to the diagnosis of cerebral vasospasm and might be useful in the clinical application of these techniques.
Demographic Characteristics and Type of Treatment
The demographic distribution of the patients included in this study reproduces the general characteristics of patients with aneurysmal SAH that have been reported in the past. There was a predominance of female patients, 33, 41, 59, 60 and the age range and distribution were similar to those observed in earlier series. 63 We included in our study patients in whom TCD, CBF, and angiography were performed in the period between Days 1 and 17 after SAH. This allows for the presence of patients for whom the risk of spasm is still low (before Day 3, 20 individuals), patients during the peak risk time (Days 8-10, 14 patients), and those in later stages after SAH (Day 11 or more, 10 individuals). The distribution of cases according to the day of treatment (Fig. 3 ) reflects our policy of treating patients with aneurysmal SAH as soon as possible. The great majority of cases were treated between Days 0 and 3 (43 patients, 63.2%).
The majority (47.1%) of the included patients underwent surgical clip placement, whereas 36.8% received GDC embolization. There were significant differences between patients treated surgically and those who underwent endovascular occlusion, including factors that significantly influence the development of cerebral vasospasm. Patients in the surgical treatment group tended to be younger (mean age 54.0 Ϯ 10.4 years), compared with a mean of 62.4 Ϯ 12.7 years for patients treated with endovascular embolization (p = 0.01). It is particularly important that the distribution of patients in the surgical group had lower grades based on both the Hunt and Hess scale and the Fisher classification (Figs. 4 and 5) , factors that are predictors of clinical and angiographic vasospasm.
The odds of having angiographic or clinical vasospasm were not significantly affected by the type of treatment received by our patients; however, several papers have been published in which investigators suggest an effect of either surgical or endovascular treatments on the development of vasospasm. 19, 67 The theoretical explanation for these findings is based on animal studies that have shown that the cisternal clot removal appears to attenuate cerebral vasospasm. 20, 52 Some studies in humans have also implied that such effects can affect the incidence of vasospasm in patients who undergo surgical clot removal. Inagawa et al. 27 published their experience with 104 patients with aneurysmal SAH who underwent clot removal from the subarachnoid space during surgery for clip occlusion of the aneurysms. Although they showed that clot removal could ameliorate cerebral vasospasm, such an effect was not sig-
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Vasospasm probability index 1107 nificant. Gruber et al., 19 published a retrospective nonrandomized study on 315 patients assigned to endovascular treatment or surgical clip placement. They found a higher incidence of delayed ischemic infarctions secondary to vasospasm in the endovascular treatment group. Nevertheless, this finding was attributed to a skewed pattern of ischemic infarcts in patients with Fisher Grade 4 lesions, for whom the incidence of vasospasm was greater. As is also evident in our study, there is a tendency to use endovascular techniques to treat patients in worse clinical condition and with worse degrees of SAH.
In agreement with our findings, another retrospective case series by Murayama et al. 50 reported an incidence of symptomatic vasospasm of 23% in patients treated with GDC embolization, an incidence that appears to be similar to that in patients undergoing surgical clip placement. The finding of some higher incidence of vasospasm among patients who undergo endovascular therapy cannot be properly assessed in nonrandomized studies, and the influence of significant cofactors, such as Hunt and Hess grades and Fisher grades, should at least be considered.
Clinical and Angiographic Vasospasm
The incidences of symptomatic and angiographic vasospasm in the population of our study were 26.5 and 48.5%, respectively. These incidences are within the range of 13 to 30% for clinical vasospasm, and are very close to what has been published for angiographic vasospasm (50-70%). 7, 13, 22, 31, 32, 64, 66, 68 Our population was selected among consecutive patients in whom TCD measurements, CBF studies, and angiographic studies were performed within 24 hours of each other. This could bias the selection of cases toward patients with more severe conditions and probable clinical and angiographic vasospasm, and has affected the number of cases in certain groups according to days after SAH. This aspect may have reduced the impact of time after bleeding in the development of the VPI. However, the inclusion of cases that were treated before the high-risk period of vasospasm as a group balanced the population, allowing incidences of clinical vasospasm that are similar to those found in the general population of patients with SAH. The diagnosis of angiographic vasospasm in our study was performed by taking objective repetitive measures of the intracranial segments of the ICA and MCA that demonstrated reductions of 25% or more of the expected diameter. The diagnosis was made without considering the clinical information, and this could explain a lower number of cases in which angiographic vasospasm was diagnosed than has been previously reported. It is possible, with strong clinical indications of vasospasm, that a reduction in the caliber of the arteries of less than 25% would prompt a diagnosis of vasospasm in regular clinical circumstances.
The diagnosis of clinical vasospasm was based on the information collected in the charts by the neurointensive care team, and no retrospective diagnosis of clinical vasospasm was attempted. This may constitute a limitation of our study that could underestimate the presence of clinical vasospasm. However, of the 13 patients with clinical vasospasm, only one did not have what was defined as angiographic vasospasm for the purpose of the study. A review of that case showed that the patient was a 44-year-old man without vasospasm in the M 1 segment, with mildly reduced calibers (20%) of the right M 2 and M 3 segments on the angiographic studies, and with reduced hemispheric CBF of 22 cm/100 g/sec.
Factors Associated With Development of Vasospasm
The mean age of patients with clinical and angiographic vasospasm did not differ significantly from that of patients without vasospasm. Even though it has been suggested that younger patients have a higher tendency to suffer vasospasm, our results and the multivariate analysis did not show that age was an independent predictor of clinical or angiographic vasospasm. Nine studies have been previ- ously published in which multivariate analysis was used to evaluate the role of age and other factors in the development of vasospasm. 5, 6, 8, 24, 35, 42, 54, 57, 58 Of these studies, six agreed with our finding that age did not influence vasospasm. 5, 8, 24, 35, 54, 57 From the other three studies, the findings of Macdonald et al. 42 deserve special attention because of the size of their study population (3567 patients) and the description of a relationship between age and vasospasm as a U-shaped curve with risk peaking between the ages of 40 and 59 years. Smaller study groups like ours may underestimate this factor. Lanzino et al. 34 studied the effect of age on outcome and vasospasm in 906 patients enrolled in the multicenter randomized trial of nicardipine. They did not find age-related differences in the incidence of angiographic vasospasm, although symptomatic spasm was more frequently reported in patients with advancing age. These findings may be explained by a reduced cerebrovascular reserve in older patients and a lessening of the ability to respond to reductions in perfusion pressure. 28, 44, 46 In our study, there was no higher incidence of vasospasm among patients with antecedents of hypertension. Five prior studies had similar findings showing no effect of hypertension on the risk of vasospasm. 5, 6, 8, 24, 35 Similarly, we did not find an association between smoking and vasospasm. Of three prior studies in which cigarette smoking was examined as a risk factor by using multivariate analysis, 8, 24, 35 only Lasner et al. 35 found that smoking was independently associated with an increased risk of clinical vasospasm.
Our study confirms that the volume of SAH is a predictor of vasospasm. The logistic regression showed that, for both clinical and angiographic vasospasm, the Fisher grade was a statistically significant factor associated with its development. Ten of 11 previous multivariate analyses confirmed these findings. 4, 5, 8, 23, 24, 35, 42, 54, 57, 58 We used the Fisher system of classification to grade the thickness of the subarachnoid clot. 16 According to this, patients with intraventricular and intraparenchymal bleeding were classified as Grade 4. No analysis of intraventricular bleeding as an independent factor was conducted. Recent studies have shown an independent role of intraventricular bleeding in the development of vasospasm, probably explained by release of spasmogenic decaying blood into the subarachnoid space. 8, 23, 42 The results of our study do not support this hypothesis; we only observed vasospasm in 12 of 30 patients with Fisher Grade 4 SAH.
A relationship between the amount of SAH and neurological grade at presentation has been shown in the past. Multivariate analysis corrects for this relationship and showed in our study that the Hunt and Hess grade is an independent factor that is significant in the diagnosis of angiographic vasospasm. Interestingly, the Hunt and Hess grade was not significant in the diagnosis of clinical vasospasm. Prior studies have also shown divided results regarding the correlation between clinical grade and vasospasm. 42 The explanation for the association is not clear. Conway and Tamargo 10 and Howington et al. 25 have found in two retrospective studies an increased prevalence of vasospasm in patients with a history of cocaine abuse. The second study also showed that cocaine adversely affected the outcome of patients with SAH. This association was found to be independent of the Hunt and Hess grade. In our study, only two patients tested positive for cocaine use on admission. This number is insufficient to draw any conclusion.
Independent Diagnostic Value of TCD Velocity, Lindegaard Ratio, and Spasm Index for Intracranial Vasospasm
Only one study has addressed the sensitivity, specificity, and predictive values of TCD velocities and the Lindegaard ratio. Vora et al. 64 found that only velocities below 120 cm/ second (NPV 94%) and greater than or equal to 200 cm/ second (PPV 87%) were reliable enough to guide clinical decision making for individual patients. Our findings are in agreement with this prior report, showing that only velocities below 121 cm/second had significant low risk of vasospasm (Ͻ 0.25) and velocities above 182 cm/second had significant high risk of vasospasm (Ͼ 0.80).
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Vasospasm probability index In Part II of the Vora et al. study, 64 despite a higher mean Lindegaard ratio for patients with moderate to severe vasospasm, the PPV and sensitivity for a ratio greater than 3 were limited to 63 and 39%, respectively. Our results differ from these findings, because the Lindegaard ratio added some information to the absolute velocities. Lindegaard ratios below 3 had low probability of vasospasm (Ͻ 0.15), whereas values higher than 4.5 had high probability of vasospasm (Ͼ 0.95). However, the values in between were not strong independent predictors of vasospasm. The published literature is divided into favorable reports of the use of the Lindegaard ratio 30, 39, 40, 43 and less supportive results. 18, 36 The logistic regression analysis in our study showed that the Lindegaard ratio was an independent significant predictor of angiographic vasospasm, and therefore it was used as part of the combined score. No prior studies have been published in which a multivariate analysis was used to study the role of spasm index in the diagnosis of vasospasm. Our analysis showed that values less than or equal to 3.5 were associated with low probability of vasospasm, whereas higher values were weaker predictors. The logistic regression showed that spasm index was a significant independent predictor of angiographic vasospasm, and therefore it was also used as part of the combined score.
Our results as well as ample evidence in the literature show a role for TCD in the monitoring of cerebral vasospasm, but also point to the need to interpret with caution the TCD velocities alone and the vital importance of combining that information with other predictive factors. We are proposing the use of a combined score based on the logistic model that weighs the clinical factors significantly associated with vasospasm after SAH with TCD velocities and CBF measures to improve the accuracy of our current approach to the diagnosis of cerebral vasospasm. We used the 133 Xe technique for the CBF measures. Because this technique is not available in the US, alternative methods of CBF assessment such as CT scanning, magnetic resonance imaging, or portable near infrared spectroscopy devices have replaced the 133 Xe evaluations. The absolute number of CBF obtained with these methodologies could be equivalently used in the VPIs.
The statistical approach that we are presenting to create combined scores has been successfully used in the past in improving the predictive value of tests that independently had limitations when attempting to define whether a certain condition exists. 62 To define the predictive factors of vasospasm in the best possible way, considering the limitations of a retrospective study, efforts were made to reduce bias through standardization of the radiological measures, clear definition of diagnostic criteria, and blinding of the clinical information for its interpretation. Careful statistical analyses were conducted, attending to the retrospective nature of the design and the particular characteristics of the information collected and their relationships. Our study provides a method that combines the clinical factors and diagnostic tests available, and this increases the efficacy of the cerebral vasospasm diagnosis for confirmation of clinical vasospasm from an average accuracy of 86.8% for the independent tests to 92.9% for the combined. For the diagnosis of angiographic vasospasm, our method increases the efficacy of the diagnosis from an average accuracy of 71.9% for the independent tests to 89.9%.
Conclusions
The TCD velocities, Lindegaard ratio, and spasm index, if used independently, are limited for the diagnosis of clinical and angiographic vasospasm. Predictive factors associated with the development of vasospasm include thickness of subarachnoid clot, the patient's neurological condition at presentation, TCD velocities, Lindegaard ratio, and, for clinical vasospasm, the ratio between TCD and CBF (spasm index). The combined scores (vasospasm angiographic and clinical VPIs) that we are presenting have superior accuracy to the independent tests and may become a useful tool for the clinician to evaluate factors involved in the development of vasospasm and to estimate the probability of cerebral vasospasm after aneurysmal SAH. The next step in the evaluation of our approach is to test the efficacy of the indexes in a prospective cohort of cases.
